Articles related to CARDIOVASCULAR DISEASE (CVD)

Lerochol (lerodalcibep-liga), a once-monthly self-administered PCSK9 inhibitor, is now commercially available as adjunctive LDL-C-lowering therapy for adults with hypercholesterolemia, including heterozygous familial hypercholesterolemia.

A Swedish national cohort analysis linked bereavement to elevated incident cardiovascular disease risk before and during the COVID-19 pandemic, with the strongest pandemic-period association following partner loss.

Online wellness messaging is reframing nicotine pouches, gum, and patches as cognitive enhancers and dementia prevention tools, despite negative results from the larger MIND trial published in December 2025.

Rare lipid disorders can drive extreme cholesterol abnormalities and early disease, making clinical recognition critical when lipid patterns don’t fit typical cardiology presentations.

According to the Gould Registry, in 5,006 patients with ASCVD, only one in three patients had LDL cholesterol even less than 70mg/dl.

“For healthy eating to be more attainable and sustainable, we recommend people focus on their overall eating pattern rather than specific nutrients or foods.” — Alice Lichtenstein, DSc, FAHA, AHA Writing Committee Chair